EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic?

ABSTRACT:

SUBMITTER: Steuer CE 

PROVIDER: S-EPMC7653125 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature